Industry investment in dementia research

Investment from industry, such as pharmaceutical and biotech companies, is critical for advancing our understanding of dementia and developing new treatments and therapies for those living with dementia. Investment from industry can help accelerate the pace of research and improve the chances of finding life-changing treatments for dementia.

industry trials clinical spend funding

ARUK report: The Economic Value of Dementia Research.

Industry and non-industry sponsored dementia trials

Industry sponsored clinical trials

ARUK report: The Economic Value of Dementia Research.

Almost all phase 3 clinical trials in the UK are funded by industry

industry funding clinical trials phase 3

ARUK report: The Economic Value of Dementia Research.